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Summary
The aim of this study was to compare the ratio of hearing loss evaluated with transient evoked otoacoustic emission 
(TEOaEs) testing in normal and hypertensive pregnant women during the first week after delivery. This was a prospec-
tive, case-control study. The hypertensive pregnancy group included 96 women with gestational hypertension preec-
lampsia, eclampsia, or HELLP syndrome, while the normal pregnancy group included age-matched 107 women with 
normal pregnancy. Postpartum first week, pure tone hearing threshold levels of all women were measured at 0.25, 1, 
2, 4 and 6 kHz. TEOaEs testing results were also recorded. all subjects also underwent a detailed ear noise and throat 
examination. Hearing loss with TEOaE during the first postpartum week was detected in seven (7.3%) women in the 
hypertensive pregnancy group and in three (2.8%) women in normal pregnancy group. mean hearing thresholds and 
individual thresholds at each of the examined frequencies (0.25-6 kHz) were similar in the two groups. Bone and air 
conduction pure tone average and TEOaE results were not statistically significantly different in the hypertensive preg-
nancy and normal pregnancy groups. Lastly, the ratios of hearing loss with TEOaE were significantly higher in women 
with HELLP syndrome compared to women with severe and mild preeclampsia.
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riaSSunTO
L’obiettivo di questo studio è stato quello di confrontare l’entità della perdita uditiva tra un gruppo di gestanti normotese ed uno di 
donne in attesa ipertese, mediante la registrazione delle otoemissioni acustiche evocate transitorie (TEOAEs) nella prima settimana del 
periodo post-partum. Trattasi di uno studio caso-controllo di tipo prospettico. Nel gruppo delle gestanti ipertese sono state incluse 96 
pazienti affette da ipertensione gestazionale, preeclampsia, eclampsia o sindrome HELLP, mentre nel gruppo delle gestanti normotese 
sono state incluse 107 pazienti di pari età con gravidanza normodecorsa. Nella prima settimana post-partum la soglia audiometrica 
tonale per le frequenze di 0.25, 1, 2, 4 e 6 kHz, è stata misurata in tutte le pazienti ed analogamente sono state registrate le TEOAEs. 
Tutte le pazienti inoltre sono state sottoposte ad accurata visita otorinolaringoiatrica. Nel nostro studio una perdita uditiva, misurata 
mediante TEOAEs nei primi 7 giorni post-partum, è stata riscontrata in 7 donne del gruppo delle pazienti ipertese, ed in 3 di quelle 
appartenenti al gruppo delle pazienti con gravidanza normodecorsa. I valori medi di soglia uditiva e quelli relativi ad ogni singola 
frequenza testata (0.25-6 kHz), sono stati simili nei due gruppi. I risultati audiometrico-tonali e TEOAEs, non hanno mostrato differenze 
statisticamente significative tra i gruppi di pazienti normotese ed affette da ipertensione gestazionale. L’entità della perdita uditiva, 
misurata mediante TEOAEs, è risultata significativamente più elevata nelle pazienti affette da sindrome HELLP, rispetto a quelle affette 
da preeclampsia di grado moderato o severo.
ParOLE  cHiavE:  Ipertensione  gestazionale  •  Preeclampsia  •  Sindrome  di  HELLP  •  Eclampsia  •  Perdita  uditiva  •  Otoemissioni 
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Introduction
Otoacoustic  emissions  (OaEs)  are  low-level  sounds 
that are produced in the cochlea and propagated back 
through the middle ear into the external ear canal where 
they can be recorded using sensitive miniature micro-
phone systems 1. OaE is natural by-product of normal 
auditory physiology. OaEs are mixtures of emissions 
arising  by  two  fundamentally  different  mechanisms; 
non-linear  distortion  induced  by  cochlear  traveling 
waves, and linear reflections of those waves from preex-
isting micromechanical impedance perturbations. These 
mechanistic differences have been used to construct a 
new taxonomy for OaEs that identifies OaEs based on 
their mechanisms of generation rather than on details of 
their measurement.
as commonly measured in the clinic, distortion-product 
and  other  evoked  OaEs  comprise  a  mixture  of  emis-
sions produced by both mechanisms 2. measurement of 
OaEs is a rapid, reproducible and objective method of 
evaluating hearing, and a non-invasive measurement of 
cochlear function. The clinical utility of OaEs has been 
extensively described in both normally hearing subjects 
and those with sensori-neural hearing loss 3. The primary 
clinical applications of these emissions appear to be in 
neonatal screening and ototoxic monitoring 4. audiologic 
examinations suggest that sudden deafness, tinnitus and 
impairment of sound localization are usually due to dys-
function of the cochlea resulting from ischaemia to the in-
ner ear and central auditory pathways 5. moreover, anato-
mo-pathologic changes such as thromboembolic events 
or vessel constriction in pathologic findings of the inner 
ear are identical and responsible for the ischaemia, but 
ischemic focuses can also damage auditory pathways and 
centres 6 7.
cochlear microcirculatory disorders associated with im-
paired local oxygenation have been considered to be a ma-
jor pathogenetic factor in hearing impairment, and most 
therapeutic  strategies  are  aimed  at  improving  cochlear 
blood flow and oxygenation 8. Preeclampsia is a common 
disorder that is a consequence of vasospasm, endothelial 
dysfunction and ischaemia 9. Preeclampsia, which effects 
microcirculation and a possible immunologic pathogen-
esis, can potentially induce damage to the inner ear and 
result in sensory neural hearing loss 10. Significant differ-
ences between healthy pregnant women and preeclamptic 
women have been found for the impairment of TEOaE, 
and these findings suggest a possible effect of preeclamp-
sia on the inner ear, at least temporarily. The aim of the 
present study was to compare the rates of hearing loss 
with TEOaEs in pregnant women with various types of 
hypertensive  disorders  as  gestational  hypertension,  su-
perimposed preeclampsia, mild or severe preeclampsia, 
eclampsia  and  HELLP  syndrome  compared  to  normal 
pregnant women during the postpartum period.
Materials and methods
Study group and design
This prospective case-control study was performed at cum-
huriyet university Hospital from June 2008 to may 2009. 
This  study  was  included  96  women  (hypertensive  preg-
nancy  group)  with  gestational  hypertension  (16  women, 
16.7%),  superimposed  preeclampsia  (4  women,  4.2%), 
mild preeclampsia (28 women, 29.2%), severe preeclamp-
sia (24 women, 25.0%), eclampsia (10 women, 10.4%) or 
HELLP syndrome (14 women, 14.6%), and 107 women 
matched for gestational week (normal pregnancy group) 
with normal pregnancy. all patients were informed of the 
audiometric  testing  and  examination  process,  informed 
consent was obtained from each participants and full medi-
cal history was obtained. gestational hypertension was de-
fined by the presence of a maternal blood pressure above 
140/90 mmHg after 20 weeks of gestation. Preeclampsia 
was defined by the presence of a maternal blood pressure 
above 140/90 mmHg after 20 weeks of gestation and pro-
teinuria of at least 300 mg/24 hour. Eclampsia was defined 
by the presence of tonic-clonic convulsions in preeclampsia. 
HELLP syndrome was defined by hemolysis, elevated liver 
enzyme levels and a low platelet count in pregnant woman.
Exclusion criteria were history of ear surgery, acute or 
chronic otitis media, history of tympanic membrane per-
foration, ear or head trauma, upper respiratory tract in-
fection at examination, intake of ototoxic drugs or em-
ployment in a noisy environment. One hundred and seven 
women matched for gestational age with a normal preg-
nancy were recruited as controls from the obstetric ward 
and followed at the inpatient clinic of cumhuriyet uni-
versity Hospital. The controls were pregnant women who 
were followed at the Obstetrics service of our hospital 
from the first trimester and who completed the pregnancy 
without complications. all subjects in the study under-
went a detailed ear nose and throat (EnT) examination 
(otoscopic, pure tone audiometry (0.25 - 4.0 kHz), and 
TEOaE (1.5-4 kHz) tests) by the same investigator (Ea). 
in order to ensure that the test results were not influenced 
by conditions such as wax or occlusion/obstruction/col-
lapse of the external auditory canal, an otoscopic investi-
gation was carried out prior to testing.
TEOaE was performed in all cases. TEOaE testing and 
analysis was conducted with a commercial device (mai-
co, ErO Scan analyzer, gmbH Salzufer, 13/14, 10587, 
Berlin gE) which had been calibrated before the study. 
disposable ear tips were used to cover the probe and seal 
them snugly in the ear canal during testing. when the test 
was complete, the results were displayed on the screen as 
“PaSS” when there was a TEOaE response, and “rE-
FEr” when there was no response to a stimulus. when a 
“rEFEr” result was obtained, the screening test was re-
peated. The click stimulus was in the 0.7-4 kHz frequency 
range at an intensity of 83 dB/SPL (± 3 dB). The test was The effects of hypertension in pregnancy on hearing
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recorded in both ears during each session. The results were 
presented in dB as an average for band range 1.5-4 kHz, 
even for pre-defined frequencies of the TEOaE spectrum, 
namely 1.5, 2, 2.5, 3, 3.5 and 4 kHz. a mean TEOaE 
amplitude below 6 dB at band range 1.5-4 kHz was con-
sidered as lack of otoacoustic emission.
conventional pure-tone audiometry using a clinical audi-
ometer (interacoustics clinical audiometer, ac 40, assen, 
denmark) was performed to measure hearing thresholds 
in dB HL at 0.25, 0.5, 1, 2, 4, and 6 kHz in 61 (67.8%) 
women in the hypertensive pregnancy group, and in 29 
(32.2%) in the normal pregnancy group. in addition, hear-
ing thresholds were also measured at 0.5, 1, 2, and 4 kHz 
using bone-conduction methods. Subjects were tested by 
the same investigator (Ea) at the Ear, nose, and Throat 
clinic during the first week after their neonates were de-
livered either naturally or by caesarean section.
Ethical considerations
The Human Ethics committee of cumhuriyet university 
approved the study in accordance with the declaration of 
Helsinki.
Statistical methods
in both the hypertensive and normal pregnancy groups, past 
medical and family history and TEOaE results were ana-
lyzed using the chi-square test, while the influence of sub-
ject age, gravidity, parity, maternal weight, arterial blood 
pressure levels, haemoglobin, haematocrit and platelet val-
ues on the results were assessed using the Student’s t-test. 
The ratio of hearing loss with TEOaE in the women with 
HELLP syndrome, mild preeclampsia, severe preeclampsia, 
gestational hypertension and eclampsia of the hypertensive 
pregnancy group were compared with Fisher’s exact test. 
Pure tone hearing thresholds and pure tone average levels 
results were analyzed using the multiple anOva test. a 
p value < 0.05 was considered statistically significant.
Results
Overall, 203 subjects were enrolled in this prospective 
case-control study which included 
96 women with gestational hyper-
tension, preeclampsia, eclampsia, 
or HELLP syndrome in the hyper-
tensive pregnancy group, and 107 
women  matched  for  gestational 
age with a normal pregnancy.
The mean ages for the hyperten-
sive and normal pregnancy groups 
were  comparable  (28.5  ±  6.8 
[range  =  17-44]  vs.  28.3  ±  6.6 
[range = 18-44], respectively). as 
indicated in Table i, there were no 
differences between the ratios of 
gravidity or parity in the two study groups, but a statisti-
cally significant difference (p < 0.005) was noted for the 
gestational age in the two groups. The mean gestational 
ages were 35.1 ± 4.1 years in the hypertensive pregnan-
cy group and 38.5 ± 7.8 years in the normal pregnancy 
group. mean body weight was also significantly different 
(t = 2.05, p < 0.005) between the hypertensive pregnancy 
and normal pregnancy groups, which were 79.6 ± 16.7 and 
73.3 ± 12.8 kg, respectively.
although not significant, a past medical history of hyper-
tension was reported for six women (17.1%) in the hyper-
tensive pregnancy group and in 10 subjects (9.5%) in the 
normal pregnancy group. additionally, a family history of 
hypertension was noted for 14 (40%) women in the hyper-
tensive pregnancy group and in 29 (27.6%) individuals in 
the normal pregnancy group. as seen in Table ii, a statisti-
cally significant difference was observed for the mean max-
imum and minimum diastolic and systolic arterial blood 
pressure levels. in addition, while haemoglobin values were 
different between the two groups, there were no significant 
differences in either haematocrit or platelet values.
The findings in Table iii indicate that the degree of hearing 
loss between the two groups was comparable (p > 0.05). 
in addition, there were no substantial differences in TE-
OaE findings between the hypertensive pregnancy [abnor-
mal n = 7 (7.3%)] and normal pregnancy [abnormal n = 3 
(2.8%)] groups. considering the ratios of hearing loss with 
TEOaE of women with HELLP syndrome, mild preec-
lampsia, severe preeclampsia, gestational hypertension and 
eclampsia in the hypertensive pregnancy group, these were 
Table I. Age, gestational age, gravidity and parity of the hypertensive and 
normal pregnancy groups.
Hypertensive 
pregnancy (n = 96)
Normal pregnancy 
(n = 107)
Age  28.5 ± 6.8 28.3 ± 6.6
Gestational age           35.1 ± 4.1* 38.5 ± 7.8
Gravidity  02.9 ± 2.5 02.9 ± 1.8
Parity  01.4 ± 1.9 01.5 ± 1.3
* (p < 0.005), hypertensive pregnancy vs. normal pregnancy. Data are expressed 
as mean ± SD.
Table II. Haemoglobin, haematocrit, platelet values, and diastolic and systolic arterial blood pressure in 
the two groups.
Hypertensive pregnancy
(n = 96) 
Normal pregnancy
(n = 107) 
p value 
MxTAs (mmHg) 161.7 ± 22.4 129.4 ± 19.6 p = 0.001
MxTAd (mmHg) 104.3 ± 19.7 080.8 ± 12.3 p = 0.001
MnTAs (mmHg) 125.7 ± 17.0 .100 ± 9.9 p = 0.001
MnTAd (mmHg) 079.7 ± 14.2 62.7 ± 7.5 p = 0.001
Hb (gr/dl) 12.8 ± 1.8 12.1 ± 1.3 p = 0.014
Hct (%) 37.6 ± 5.2 35.9 ± 3.6 p = 0.079
Platelets (1000/mm3) 201.8 ± 57.9 221.5 ± 68.1 p = 0.128
MxTAs: Maximum systolic arterial blood pressure; MxTAd: Maximum diastolic arterial blood pressure; MnTAs: 
Minimum systolic arterial blood pressure; MnTAd: Minimum diastolic arterial blood pressure; Hb: Haemoglobin; Hct: 
Haematocrit; Plt: Platelets. Data are expressed as mean ± SD.E.E. altuntaş et al.
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significantly higher in women with 
HELLP  syndrome  compared  to 
those with severe and mild preec-
lampsia (p < 0.05). clinical charac-
teristics and the number of women 
identified with hearing loss in the 
hypertensive pregnancy group are 
shown in Table iv.
Pure-tone  hearing  thresholds 
(HTLs) were essentially identical 
for both air and bone conduction 
audiometry,  and  audiometry  re-
sults were recorded for both ears 
of 90 (44.3%) women [61 (67.8%) 
in  the  hypertensive  pregnancy 
group; 29 (32.2%) in the normal 
pregnancy group]. mean HTLs at 
each of the examined frequencies 
were directly compared between 
two groups.
as shown in Table v, there were 
no statistically or clinically signif-
icant differences between the two 
ears when mean pure-tone hear-
ing thresholds (HTLs) were com-
pared for each subject. women in 
both groups were compared with bone and air conduction 
pure tone average, but no statistically significant differ-
ences were found between groups.
Table III. Pure -tone hearing thresholds for [air conduction (AC) and bone conduction (BC)] the hyperten-
sive and normal pregnancy groups.
Frequency (kHz) Hypertensive pregnancy
HTLs in dB (n = 96)
Normal pregnancy
HTLs in dB (n)
0.25 kHz Right ear AC (dB)  16.2 ± 10.9 18.6 ± 16.1
Left ear AC (dB)  13.4 ± 7.20 18.4 ± 20.3
0.5 kHz Right ear BC (dB)  12.3 ± 7.90 12.2 ± 8.50
AC (dB)  13.1 ± 10.0 15.2 ± 15.2
Left ear BC (dB)  10.8 ± 6.80 11.2 ± 11.9
AC (dB)  10.90 ± 7.100 13.6 ± 20.2
1 kHz Right ear BC (dB)  9.9 ± 7.4 10.5 ± 6.70
AC (dB)  9.91 ± 7.44 13.3 ± 12.6
Left ear BC (dB)  8.7 ± 6.7 09.7 ± 11.2
AC (dB)  8.9 ± 6.8 11.9 ± 19.6
2 kHz Right ear BC (dB)  10.9 ± 8.00 11. ± 7.8
AC (dB) 10.7 ± 7.90 11.7 ± 10.8
Left ear BC (dB)  9.3 ± 6.9 09.5 ± 11.2
AC (dB)  9.3 ± 6.8 0.11 ± 19.3
4 kHz Right ear BC (dB 13.2 ± 8.80 13.3 ± 9.60
AC (dB) 13.7 ± 11.0 .014 ± 11.7
Left ear BC (dB 11.6 ± 7.30 11.9 ± 11.7
AC (dB) 12.3 ± 8.10 13.5 ± 19.4
6 kHz Right ear AC (dB) 17.9 ± 11.6 18.8 ± 16.3
Left ear AC (dB) 15.4 ± 9.90 15.9 ± 19.9
There were statistically significantly differences between groups (F = 0.78, p = 0.701). (dB): decibels; (HTLs): hearing 
thresholds; (kHz): kilohertz; (SD): standard deviation. Data are expressed as mean ± SD.
Discussion
according to our findings, hypertension in pregnancy may 
not cause hearing impairment in the postpartum period, 
but it may be associated with hearing loss in women with 
HELLP syndrome. no clinically significant differences 
were  found  when  comparing  mean  pure-tone  hearing 
thresholds (HTLs) between the hypertensive pregnancy 
and normal pregnancy groups.
Some form of hearing loss is the most common senso-
ry disorder in the united States, affecting more than 36 
million people, 80% of which are irreversible. There are 
many factors that cause hearing loss in adults, such as ex-
posure to intense and/or continuous noise, inhalation of 
toxic substances, ingestion of ototoxic drugs, metabolic 
and circulatory alterations, infections, different types of 
injuries and genetic inheritance 11 12. Hypertension is a 
common vascular disease that can cause structural chang-
es in blood vessels, heart and circulatory system pathol-
ogy 13. arterial hypertension is a risk factor for hearing 
loss. various studies have been carried out in this regard, 
some of which have indicated that hypertension may be a 
risk factor for hearing loss 14-17. arterial hypertension may 
directly affect hearing in a number of ways. High pressure 
in the vascular system may cause inner ear haemorrhage, 
which  may  cause  progressive  or  sudden  hearing  loss. 
when blood viscosity is increased, the capillary blood 
flow and oxygen load are reduced which causes tissue hy-
poxia, thus causing hearing deficits and hearing loss in 








Gestational hypertension 16 (16.7%) 1 (14.3%)
Superimposed preeclampsia  4 (4.2%) 0 
Mild preeclampsia  28 (29.2%) 1 (14.3%)
Severe preeclampsia 24 (25.0%) 0 
Eclampsia 10 (10.4%) 1 (14.3%)
HELLP syndrome 14 (14.6%)* 4 (57.1%)
* p < 0.05 vs. mild and severe preeclampsia subgroups.









Left ear AC 9.7 ± 6.4 12.3 ± 19.4 NS
Left ear BC 9.5 ± 6.2 10.2 ± 11.1 NS
Right ear AC 11.6 ± 7.70 12.7 ± 12.4 NS
Right ear BC .11 ± 7.9 10.4 ± 6.70 NS
There were no statistically significantly differences between groups (F = 1.32, 
p = 0.268, p > 0.05). air conduction (AC) and bone conduction (BC). Data are 
expressed as mean ± SD. NS: not significant.The effects of hypertension in pregnancy on hearing
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hypertensive patients. moreover, arterial hypertension may 
cause ionic changes in cell potentials, thus causing hearing 
loss 11 18-20. Friedland et al.  14 showed that low-frequency 
hearing loss is associated with underlying cardiovascular 
disease, and as audiogram patterns correlate strongly with 
peripheral arterial disease it may represent a screening 
test. agrawal et al. 15 compared the effects of cardiovas-
cular risk factors and noise exposure on frequency-spe-
cific audiometric thresholds among uS adults, and those 
representing cardiovascular disease were associated with 
both high- and low-frequency hearing loss. Przewoźny 
et al. 16 investigated risk factors of sensorineural hearing 
loss in patients with early stages of ischaemic stroke, and 
showed the highest risk of hearing loss in the group of 
ischaemic stroke patients occurred for older individuals, 
particularly men with tinnitus, lacunaria stroke, multiple, 
bilateral ischaemic focuses and arterial hypertension. ni 
et al. 17 investigated the relationship between hearing loss, 
blood pressure and arterial compliance of female workers 
exposed to occupational noise in a textile mill, and found 
that those with low artery compliance or with high blood 
pressure may suffering from hearing loss.
The pathogenesis of preeclampsia is complex and incom-
pletely understood, although it may be associated with 
maternal multiorgan failure, coagulopathy, maternal and 
foetal death and vasospasm, microthrombus and ischae-
mia in the peripheral tissue 21-23. Thus, preeclampsia may 
cause hearing loss. Bakhshaee et al. 23 found a significant 
difference in TEOaEs of neonates from healthy moth-
ers  compared  to  those  from  hypertensive  pregnancies 
in the first exam. at follow-up tests two and four weeks 
later, TEOaEs did not show any significant differences. 
Therefore, it seems that preeclampsia might have some 
transient effects on hearing. also, this possible transient 
effect of pregnancy toxaemia may be seen in the hearing 
of mothers. Bakhshaee et al. 10 reported that damage to the 
inner ear hair cells during preeclampsia was possible. in 
the same study, they evaluated hearing in 37 preeclamptic 
and 38 healthy women with TEOaE and found significant 
differences between the two groups. These findings indi-
cate the possible effect of preeclampsia on the inner ear, at 
least temporarily 10. The present study is the first to show 
that  pregnancy  toxaemia  may  have  effects  on  hearing. 
Seven (7.3%) women with hypertension and three (2.8%) 
healthy women with TEOaE disturbances consistent with 
hearing impairment were noted in the postpartum period, 
although there was not a statistically significant difference 
between the two groups.
Each of the two studies by Bakhshaee et al. 10 23 suggest 
that preeclampsia may have some temporary effects on 
hearing in both newborns and mothers. However, our re-
sults do not support the results of Bakhshaee et al. 10.
consequently, we found no significant difference between 
hypertensive  and  healthy  pregnant  women  in  terms  of 
hearing evaluation. damage to the inner ear hair cells con-
sequent to hypertension during pregnancy is possible, but 
results of our study suggest that ischaemia of the inner ear 
caused by vasospasm and microthrombus by hypertension 
during pregnancy does not result in hearing impairment in 
the postpartum period.
undoubtedly,  the  aetiology  of  hearing  impairment  is 
multifactorial, and environmental, genetic and individual 
differences may be important in the development of the 
hearing loss. There are, however, some limitations of our 
study; a relatively small number of women were evalu-
ated, subjects with more than one disease causing hyper-
tension in pregnancy were included in the study, and the 
study was performed in a single centre.
Conclusions
Hearing loss may develop during the early postpartum 
period in women with HELLP syndrome, but other vari-
ants of hypertensive disorders in pregnancy do not impair 
hearing function. Further studies are needed to assess the 
effect of subtypes of hypertensive pregnancy disorders on 
hearing impairment after delivery.
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